ResultsIQ

ResultsIQ › Latest results › Aster DM Quality Care Limited

Aster DM Quality Care Limited Q2 FY27 results press release summary

NSE: ASTERDM · BSE: 540975

Results press release of 6 Nov 2026, summarised by AI from the filing.

Q2 FY27 revenue ₹2,829 cr, up 19% YoY, on higher volumes, greater clinical complexity and a favourable payor mix.

Key takeaways

  1. Revenue Q2 FY27 revenue ₹2,829 cr, up 19% YoY, on higher volumes, greater clinical complexity and a favourable payor mix.
  2. First quarter Q2 FY27 was the first full quarter as the combined Aster DM Quality Care entity after the merger.
  3. Occupancy Occupancy rose 335 bps to 68% on patient volume growth in key specialties and MVT patient flows.
  4. Integration The quarter involved navigating organisational changes associated with integrating the merged entity.

Original filing on BSE

Aster DM Quality Care Limited Q2 FY27 results

As filed: Revenue ₹2,829 cr (+136% year on year), EBITDA ₹663 cr (+165% year on year), PAT ₹322 cr (+166% year on year), EBITDA margin 23.5% (+256 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹1,311 cr (+22% year on year), EBITDA ₹264 cr (+28% year on year), PAT ₹29.3 cr (+38% year on year), EBITDA margin 20.2% (+96 bps). Score 54 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend; profit before exceptional items growth was in line with it. EBITDA margin rose 96 bps year on year. Other income 43% of PBT. Tax rate 56%. Profit lagged EBITDA because of depreciation, interest or other income, not the business. Profit before exceptional items rose ₹54.8 cr on a year ago, more than the ₹23.0 cr it added the year before. Share price after the results: −6.7% in 30 days (Nifty 500: −2.0%).
  • Q4 FY26: Revenue ₹1,182 cr (+18% year on year), EBITDA ₹233 cr (+21% year on year), PAT ₹154 cr (+79% year on year), EBITDA margin 19.7% (+47 bps). Score 48 of 100, In line with trend. Revenue, EBITDA and profit growth were above the company's own trend. EBITDA margin rose 47 bps year on year. Tax rate 6%. Consolidated profit +79% but standalone -55%. Share price after the results: +3.9% in 29 days (Nifty 500: −0.1%).
  • Q3 FY26: Revenue ₹1,186 cr (+13% year on year), EBITDA ₹211 cr (+12% year on year), PAT ₹58.7 cr (+9% year on year), EBITDA margin 17.8% (−18 bps). Score 36 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it; profit before exceptional items growth was below it. EBITDA margin fell 18 bps year on year. Other income 25% of PBT. Tax rate 40%. Profit fell 23% from last quarter. Share price after the results: +14.8% in 28 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹1,197 cr (+10% year on year), EBITDA ₹250 cr (+14% year on year), PAT ₹121 cr (+14% year on year), EBITDA margin 20.9% (+72 bps). Score 51 of 100, In line with trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was above it. EBITDA margin rose 72 bps year on year. Share price after the results: −7.6% in 29 days (Nifty 500: +1.4%).
  • Q1 FY26: Revenue ₹1,078 cr (+8% year on year), EBITDA ₹207 cr (+27% year on year), PAT ₹94.0 cr (−98% year on year), EBITDA margin 19.2% (+293 bps). Score 50 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA growth was above it; profit growth was below it. EBITDA margin rose 293 bps year on year. Share price after the results: +1.4% in 30 days (Nifty 500: −2.5%).
  • Q4 FY25: Revenue ₹1,000 cr (+3% year on year), EBITDA ₹192 cr (+21% year on year), PAT ₹86.0 cr (+69% year on year), EBITDA margin 19.2% (+288 bps). Score 43 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were above it. EBITDA margin rose 288 bps year on year. Other income 31% of PBT. Tax rate 5%. Revenue fell 5% from last quarter. Share price after the results: +1.4% in 30 days (Nifty 500: +1.4%).
  • Q3 FY25: Revenue ₹1,050 cr (−72% year on year), EBITDA ₹189 cr (−67% year on year), PAT ₹64.0 cr (−47% year on year), EBITDA margin 18.0% (+277 bps). Score 11 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend; profit before exceptional items growth was below it. EBITDA margin rose 277 bps year on year. Other income 31% of PBT. Tax rate 36%. Revenue fell 3% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Aster DM Quality Care Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.